The fourth grader was referred to a specialist in Lexington, who discovered he was a good candidate for a new type of ...

The Medical University of South Carolina in Charleston will be the first clinical trial site in the country to test a new ...

The Medical University of South Carolina in Charleston is set to be the first clinical trial site in the country to test a new cochlear implant for people with hearing loss.

Discover Cochlear Limited's Q2 2025 earnings insights: strong implant growth, upcoming product launches, and strategic investments amid Services ...

The Hong Kong Patent Office granted HK Patent No. HK40097814 to Envoy Medical Corporation on January 3, 2025. The title is Programming of Cochlear Implant Accessories. This patent relates to a system ...

Cochlear is the market leader in cochlear implants with consistent share of roughly 60% across developed markets. Cochlear implants became the standard of care many years ago for children in ...

The broker noted that the Cochlear implant unit growth was 6% year over year with stable pricing. The company continues to expect growth of around 10% for FY25, implying an uplift in the second half.

Pacific ENT Devices Market: Focus on Product Type, End User, and Country - Analysis and Forecast, 2024-2033" report has been ...

Wilsons analyst Shane Storey downgraded Cochlear Limited (CHEOF – Research Report) to a Hold today and set a price target of A$280.00. The company’s shares closed last Friday at $166.25.